Related Experiment Video

Updated: Aug 4, 2026

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
08:18

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene

Published on: December 31, 2014

Role of MEK/ERK pathway in the MAD2-mediated cisplatin sensitivity in testicular germ cell tumour cells

M K L Fung1, H-W Cheung, M-T Ling

  • 1Cancer Biology Group, Department of Anatomy, Laboratory Block, Faculty of Medicine, The University of Hong Kong, 21 Sassoon Road, Hong Kong, SAR, China.

British Journal of Cancer
|August 2, 2006
PubMed

Insights

Mitotic arrest deficient-2 (MAD2) influences cisplatin sensitivity in testicular germ cell tumors (TGCT). High MAD2 expression correlates with better response, while its downregulation may indicate resistance to chemotherapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Testicular germ cell tumors (TGCT) are common in young males.
  • Cisplatin resistance leads to treatment failure in a significant number of TGCT patients.
  • Mitotic arrest deficient-2 (MAD2) has been identified as a mediator of cisplatin sensitivity in other cancers.

Purpose of the Study:

  • To investigate the role of MAD2 in cisplatin sensitivity in TGCT cells.
  • To elucidate the molecular mechanisms underlying MAD2's function in TGCT cisplatin response.

Main Methods:

  • Utilized 10 TGCT cell lines.
  • Correlated MAD2 expression with cisplatin sensitivity.
  • Investigated the involvement of the MEK pathway.
  • Used an MEK inhibitor (U0126) and MAD2 inactivation (dominant-negative construct).

Main Results:

  • Increased MAD2 expression correlated with higher cisplatin sensitivity in TGCT cells.
  • MAD2 expression was associated with MEK pathway activation.
  • MEK inhibition protected high-MAD2 cells from cisplatin-induced apoptosis.
  • MAD2 inactivation led to MEK pathway suppression and cisplatin resistance.

Conclusions:

  • MAD2 plays a crucial role in mediating cisplatin sensitivity in TGCT.
  • The MEK pathway is involved in the MAD2-mediated response to cisplatin in TGCT.
  • Downregulation of MAD2 may serve as a biomarker for identifying cisplatin-resistant TGCT.

More Related Videos

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Spatial and Temporal Analysis of Active ERK in the C. elegans Germline08:40

Spatial and Temporal Analysis of Active ERK in the C. elegans Germline

Published on: November 29, 2016

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Meiosis II02:02

Meiosis II

Meiosis II entails cell division and segregation of the sister chromatids, resulting in the production of four unique haploid gametes. The steps for meiosis II are similar to mitosis, except that meiosis II occurs in haploid cells, whereas mitosis occurs in diploid cells.
The timing and cell division patterns of meiosis differ between males and females. In male meiosis, the centrosomes are part of the formation of the meiotic spindle. However, in oocytes, including that of humans, Drosophila,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...